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INTRODUCTION
Cannabis is becoming more available as it is legalized across the 
country.1 There has been a rise in accidental pediatric cannabis poi-
soning in Colorado since its legalization.2 While recreational use of 
cannabis has not been legalized in the state of Kansas, its proximity 
to Colorado makes cannabis easily available.  
Children aged one to four years of age are especially at risk for 
accidental poisoning due to exploratory ingestion.3 With cannabis’s 
growing popularity, its modes of delivery have evolved to include 
vaping, dabbing (inhaling small quantities of a concentrated or vapor-
ized drug), topical applications, and oral ingestion through baked 
goods and candies.4 Oral ingestion puts children particularly at risk of 
acute intoxication due to the appealing nature of edibles and its easy 
consumption. Furthermore, delta-9-tetrahydrocannabinol (THC) 
often is highly concentrated in edibles. When smoked, the maximum 
plasma concentration of THC is achieved within 0.02-0.5 hours 
versus 1-3.4 hours with oral consumption.5
THC is the main psychoactive ingredient in cannabis that con-
tributes to its CNS toxicities.6 Cannabidiol (CBD) is the main 
non-psychoactive ingredient in cannabis that is being studied for its 
effectiveness in treating epilepsy. Through selective breeding of the 
hemp plant Cannabis sativa, the THC to cannabidiol content in can-
nabis has increased from 14 times in 1995 to about 80 times in 2014.7
The adverse effects of cannabis intoxication in adults has been 
well-defined,8 but less is known about how it presents in children. 
There have been different case reports of acute cannabis intoxica-
tion in children presenting with ataxia, lethargy, tremors, coma, 
and seizures.8,9 Neurological impairment is the main manifestation 
of cannabis intoxication in children under 3-years-old.10 However, 
the pharmacokinetics of cannabis in children is still unknown.11 Case 
reports depicting these side effects have dated back to 1983 in Italy12 
and 2005 in the United States.2
We report two cases of children presenting with new-onset sei-
zures precipitated by acute cannabis intoxication. Physicians should 
consider cannabis ingestion in their differential diagnosis when a 
child presents with seizures and other neurological impairments.
CASE REPORT
Case 1. A previously healthy 3-year-old male was admitted for care 
of a new-onset seizure. The patient’s mother reported that the child 
climbed in bed with her on the morning of admission complaining of 
a headache and dizziness. He had a generalized seizure for 30 - 45 
seconds and was postictal afterward. A minor head trauma three days 
prior to admission was noted by the mother, but it was noncontribu-
tory to the presentation. 
The child was a term baby without significant complications. 
According to the mother, he had normal growth and development. 
He had asthma and allergies, for which he took albuterol and cetiri-
zine as needed. He was up-to-date on his immunizations and had no 
known drug allergies, prior hospitalizations, or surgeries. The child 
had routine visits to a primary care physician and dental care. 
The mother reported no family history of seizures and the extend-
ed family history was not significant for any childhood illnesses or 
diseases. The mother had depression, anxiety, and Borderline Per-
sonality Disorder. The patient was living with his mother, her female 
friend, and the friend’s two small children. The mother denied any 
domestic violence or possible substances in the home. The mother 
adamantly denied any cannabis in the home. 
The patient was given levetiracetam on admission. Physical exam 
was normal and he was developmentally appropriate and neurologi-
cally back to baseline. No further seizures occurred. Before drug 
testing was conducted, rectal diazepam was prescribed as needed for 
future episodes. A head computed tomography (CT) scan and brain 
magnetic resonance imaging (MRI) were unremarkable. Urinalysis 
was negative and electroencephalogram (EEG) was normal. A urine 
drug screen (UDS) as part of the initial workup for new-onset seizure 
was positive for cannabis. A quantitative urine toxicology test showed 
THC levels were 750 ng/mL, which is the highest the test would read. 
Other drugs, ethanol, acetaminophen, and salicylates were negative. 
After investigation, the source of THC exposure could not be 
determined. However, since the levels were high, the intoxication was 
unlikely to be from passive smoke inhalation and likely from THC-
laced edibles. Ultimately, the lack of history to identify the source of 
exposure prompted concern for lack of supervision and safety of the 
child. The family was referred to Kansas Department for Children 
and Families (DCF).  
Case 2. A 3-year-old female was admitted by emergency medical 
services (EMS) with complaints of altered mental status, lethargy, 
vomiting, and seizure activity. The parents reported that the child 
was at the mother’s house in the days leading up to admission. The 
child took a nap as usual, but she was unresponsive when the mother 
went to check on her. When EMS arrived, the patient was lethargic, 
vomiting, and seizing. Her Glasgow Coma Score was 6 at the scene.
The child had no prior hospitalizations, surgeries, or injuries. She 
had normal growth, development, and behavior. The mother’s family 
was significant for a history of seizures. 
A head CT was negative, and a brain MRI and ECG were normal. 
The patient’s UDS was negative for acetaminophen and salicylate 
and positive for THC and benzodiazepines. The benzodiazepines 
were given by EMS for the seizures. Confirmatory urine testing was 
completed with maximum levels of THC reported. 
When questioned about the positive THC drug screen, the mother 
reported that she had been to Colorado recently and brought back 
THC-containing brownies and other edibles. The mother claimed 
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to have discarded the edibles and denied any knowledge of the child 
ingesting any THC-containing foods. The mother denied regular use 
of any substances. 
The child improved overnight and was clinically approved for dis-
charge. The Kansas DCF was alerted and followed up with the family.
DISCUSSION
With the increasing availability of cannabis products, acute intoxi-
cation from accidental ingestion should be considered when a child 
presents with new-onset seizure. While the mode of cannabis intoxi-
cation was not determined in the first case, the high levels of THC and 
age of the child suggested oral ingestion. The child had experienced a 
minor head trauma three days prior to admission, and while concus-
sion was ruled out, the trauma could have been a contributing factor 
to the new-onset seizure. 
THC-containing products may lower the seizure threshold in a 
predisposed individual with an associated family history,2 such as 
with the patient in the second case. However, the pediatric pharma-
cokinetics of THC have not been well established. A recent study 
found the mean peak plasma concentration of THC extract to be 
two to seven hours and elimination half-life to be 4.0 hours in pedi-
atric patients, but this was conducted in a small population (n = 9) 
with a median age of 11 years and controlled dosing.13 In adults, THC 
is detectable in plasma for over one week, and its metabolites can 
persist in feces and urine for several weeks.14 Obtaining quantitative 
levels of THC in plasma and urine or feces can help determine tem-
porality in a patient with an unknown exposure. 
In the past, cannabis use has not been associated with causing the 
onset of seizures. We postulate this is due to the lower concentrations 
of THC typically found in cannabis products until recent years. Due 
to the increasing use of THC-containing products, physicians should 
consider a toxicology screen including common drugs of abuse in 
pediatric patients presenting with new-onset seizure. Upon any posi-
tive screen, a quantitative serum test also should be ordered to assist 
the diagnosis. Treatment of acute cannabis intoxication is mainly 
supportive care; an accurate diagnosis can avoid unnecessary tests 
and interventions. Our report emphasized including acute cannabis 
intoxication in the differential diagnosis of pediatric patients at risk 
(one to four years of age) of accidental ingestion who present with 
new-onset seizure. 
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